Progressive prothrombotic state in women with advancing HIV disease

Journal of Acquired Immune Deficiency Syndromes

Volumn 42, Issue 5, 2006, Pages 572-577

  Levine, Alexandra M ^a   Vigen, Cheryl ^a   Gravink, Jay ^a   Mack, Wendy ^a   Watts, C Heather ^b   Liebman, Howard A ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Coagulation abnormalities in HIV disease

Indexed keywords

BLOOD CLOTTING FACTOR 8; CD4 ANTIGEN; LUPUS ANTICOAGULANT; PROTEIN S;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MAJOR CLINICAL STUDY; PATIENT SELECTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SAMPLE SIZE; SEROPREVALENCE; THROMBOGENESIS; VEIN THROMBOSIS;

ADULT; BLOOD COAGULATION DISORDERS; FACTOR VIII; FEMALE; HIV INFECTIONS; HUMANS; LUPUS COAGULATION INHIBITOR; PROTEIN S; VENOUS THROMBOSIS;

EID: 33746665311     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qai.0000230320.78288.79     Document Type: Article

References (27)

1. Iranzo A, Domingo P, Cadafalch J, Sambeat MA. Intracranial venous and dural sinus thrombosis due to protein S deficiency in a patient with AIDS. J Neurol Neurosurg Psychiatry. 1998;64:688.
2. Park KL, Marx JL, Lopez PF, et al. Noninfectious branch retinal vein occlusion in HIV-positive patients. Retina. 1997;17:162-164.
3. George SL, Swindells S, Knudson R, et al. Unexplained thrombosis in HIV-infected patients receiving protease inhibitors: report of seven cases. Am J Med. 1999;107:624-630.
4. Sullivan PS, Dworkin MS, Jones JL, et al. Epidemiology of thrombosis in HIV-infected individuals. The Adult/Adolescent Spectrum of HIV Disease Project. AIDS. 2000;14:321-324.
5. Fultz SL, McGinnis KA, Skanderson M, et al. Association of venous thromboembolism with human immunodeficiency virus and mortality in veterans. Am J Med. 2004;116:420-423.
6. Bissuel F, Berruyer M, Causse X, et al. Acquired protein S deficiency: correlation with advanced disease in HIV-1-infected patients. J Acquir Immune Defic Syndr. 1992;5:484-489.
7. Stahl CP, Wideman CS, Spira TJ, et al. Protein S deficiency in men with long-term human immunodeficiency virus infection. Blood. 1993;81:1801-1807.
8. Sorice M, Griggi T, Arcieri P, et al. Protein S and HIV infection. The role of anticardiolipin and anti-protein S antibodies. Thromb Res. 1994;73:165-175.
9. Erbe M, Rickerts V, Bauersachs RM, et al. Acquired protein C and protein S deficiency in HIV-infected patients. Clin Appl Thromb Hemost. 2003;9:325-331.
10. Toulon P, Lamine M, Ledjev I, et al. Heparin cofactor II deficiency in patients infected with the human immunodeficiency virus. Thromb Haemost. 1993;70:730-735.
11. Bloom EJ, Abrams DI, Rodgers G. Lupus anticoagulant in the acquired immunodeficiency syndrome. JAMA. 1986;256:491-493.
12. Stimmler MM, Quismorio FP Jr, McGehee WG, et al. Anticardiolipin antibodies in acquired immunodeficiency syndrome. Arch Intern Med. 1989;149:833-835.
13. Ginsburg KS, Liang MH, Newcomer L, et al. Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis. Ann Intern Med. 1992;117:997-1002.
14. Fauci AS, Schnittman SM, Poli G, et al. NIH conference. Immunopathogenic mechanisms in human immunodeficiency virus (HIV) infection. Ann Intern Med. 1991;114:678-693.
15. Emilie D, Peuchmaur M, Maillot MC, et al. Production of interleukins in human immunodeficiency virus-1-replicating lymph nodes. J Clin Invest. 1990;86:148-159.
16. Hack CE. Tissue factor pathway of coagulation in sepsis. Crit Care Med. 2000;28:S25-S30.
17. Nawroth PP, Handley DA, Esmon CT, et al. Interleukin 1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity. Proc Natl Acad Sci U S A. 1986;83:3460-3464.
18. Taylor F, Chang A, Ferrell G, et al. C4b-binding protein exacerbates the host response to Escherichia coli. Blood. 1991;78:357-363.
19. O'Donnell J, Tuddenham EG, Manning R, et al. High prevalence of elevated factor VIII levels in patients referred for thrombophilia screening: role of increased synthesis and relationship to the acute phase reaction. Thromb Haemost. 1997;77:825-828.
20. Kraaijenhagen RA, Ankerint PS, Koopman MMW, et al. High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism. Thromb Haemost. 2000;83:5-9.
21. Barkan SE, Melnick SL, Preston-Martin S, et al. The Women's Interagency HIV Study. WIHS Collaborative Study Group. Epidemiology. 1998;9:117-125.
22. Vaara I, Jonsson M. Preservation of factor VIII activity in plasma by different freezing techniques, as determined with a chromogenic microtray assay. Scand J Clin Lab Invest. 1989;49:161-164.
23. Wolf M, Boyer-Neumann C, Martinoli JL, et al. A new functional assay for human protein S activity using activated factor V as substrate. Thromb Haemost. 1989;62:1144-1145.
24. Triplett DA, Barna LK, Unger GA. A hexagonal (II) phase phospholipid neutralization assay for lupus anticoagulant identification. Thromb Haemost. 1993;70:787-793.
25. Guidelines on testing for the lupus anticoagulant. Lupus Anticoagulant Working Party on behalf of the BCSH Haemostasis and Thrombosis Task Force. J Clin Pathol. 1991;44:885-889.
26. Khor LLC, Muhlestein JB, Carlquist JF, et al. Sex- and age-related differences in the prognostic value of C-reactive protein in patients with angiographic coronary artery disease. Am J Med. 2004;117:657-664.
27. Galli M, Luciani D, Bertolini G, et al. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood. 2003;101:1827-1832.